Memorial Sloan Kettering Cancer Center

• by EVOMT
• 2020-03-19

The Memorial Sloan Kettering Cancer Center (MSKCC) is a private cancer center with a long history and a large scale in the world. The early predecessor was the New York Cancer Hospital, founded by John J. Astor and his wife in 1884, which began to be located on the Upper West Side of Manhattan. In 1936, John D. Rockefeller, Jr. donated a piece of land on York Avenue to the hospital. In 1939, the Memorial Hospital was established at this new site. In the 1940s, two former heads of General Motors, Alfred P. Sloan and Charles F. Kettering, established the Sloan Kettering Institute (SKI) near the Memorial Hospital. In 1948, SKI and Memorial Hospital began to cooperate. In 1980, the Memorial Sloan Kettering Cancer Center was officially merged and established. In 2004, the center established Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences to provide PhD education in cancer biology.

For a century, it has been committed to patient care, research innovation, and better understanding, diagnosis, and treatment of cancer. As one of the best cancer centers in the United States, the Memorial Sloan Kettering Cancer Center is one of the 41 comprehensive cancer centers designated by the National Cancer Institute in the United States.

Currently, the Memorial Sloan Kettering Cancer Center has more than 12000 employees, including 834 attending physicians and 143 members of the Sloan Kettering Institute. In 2011, the hospital accepted 24486 patients and 535900 outpatients. The center consists of physicians, surgeons, oncologists, radiologists, radiation oncologists, and pathologists to jointly develop personalized treatment plans for each patient, providing personalized medication, and effective cancer pain control.

In memory of the Sloan Kettering Cancer Center, we have focused on cancer for a century. Doctors in hospitals have unparalleled skills in diagnosing and treating various cancers, and use advanced and innovative methods to increase the likelihood of cure. The previous close cooperation between doctors and researchers has enabled new drugs and treatment methods to be put into clinical use faster, providing advanced treatment technologies for patients.

The Memorial Sloan Kettering Cancer Center specializes in setting up centers for adult cancer, child and adolescent cancer, health care, and research. The Adult Patient Treatment Program has over 40 cancer specialties, and there are 525 clinical trials that patients can choose to participate in. In addition, it is very distinctive in disease risk prediction and disease screening, especially providing patients with self-developed cancer prediction tools based on a large number of patient data. It provides 15 kinds of cancers, including breast cancer, bladder cancer, liver cancer, lung cancer, prostate cancer, with information on disease risk, recurrence probability, rehabilitation prediction and other aspects. It is easy to operate and use, These personalized information can be obtained by simply filling in the required information online by a doctor or patient.

The Children's Patient Treatment Project Branch has 11 children's cancer specialties, providing multidisciplinary comprehensive team treatment services for children's patients, including oncology, radiology, immunology, etc., as required. In the field of cancer treatment, it includes providing surgical treatment, radiotherapy, chemotherapy, and new treatments such as interventional radiation therapy and immunotherapy. In ophthalmology, blood& Spinal cord transplantation and pediatric surgery are in a world position. Its specialized clinical trials for children are also well known. According to current data, these clinical trials have helped children patients provide a cure rate of 70% overall, and the cure rate for some children with malignant tumors has increased by 90%. They have made outstanding contributions to curing children with cancer and prolonging their lives and improving their quality of life.

Memorial Sloan Kettering Cancer Center has always been famous in the United States for the treatment of breast cancer, bone cancer and retinoblastoma in children. To commemorate the success of Sloan Kettering Cancer Center in injecting chemotherapy drugs directly into ocular tumors worldwide, eliminating cancer cells, protecting vision, and reducing toxic and side effects. Every year, we receive about 1500-2000 cases of eye cancer patients from around the world, with a survival rate of 99%, and 90% of patients can maintain their vision.